Dry AMD involves ARPE-19 atrophy with drusen accumulation while wet AMD involves abnormal vascular endothelial growth factor (VEGF) secretion and exudates in the photoreceptor layer, causing a decrease in the patient’s best visual acuity. The gene discussed is VEGFA; the disease is Atrophy.